Police dog Jimmy helps catch murder accused

Bengaluru, Aug 6: No private hospital in Karnataka can turn away a patient without attending to him or her, irrespective of the Coronavirus status, an official has said.

"Private medical establishments shall not deny treatment and admission to any patient approaching the establishment irrespective of the fact that such patient may or may not be suffering from Covid-19," an official from the state Health and Family Welfare Department said on Wednesday.

Likewise, no private hospital can insist on a patient for a Covid-19 test report, said the official invoking the Disaster Management Act.

"The establishments also cannot insist for Covid test report," he said, directing all private hospitals to strictly abide by their responsibilities.

According to the department, it is the duty of every private hospital to provide first aid and take lifesaving steps when any patient approaches it.

"It is the duty of every private medical establishment to provide first aid and take lifesaving measures to stabilise the patient," he said.

The department also invoked statutes from Karnataka Medical Establishments Act 2017, under sections 11 and 11 (A) to drive home the message.

The directives assume significance at a time when several cases of private hospitals denying admissions and fleecing patients across the state have emerged.

"It has been noticed that some of the private hospitals are refusing treatment and admission to emergency patients, causing distress and this has resulted in complications, leading to death in certain cases," said the official.

The district authorities have been directed to take action on the erring hospitals as the department reiterated the responsibilities of private medical establishments.

Bengaluru, Aug 2: Bengaluru based Centre for Advanced Research and Development (CARD), the research wing of organisation De scalene has come up with a device called "SHYCOCAN" (Scalene Hypercharge Corona Canon) which neutralizes the coronavirus.

Speaking to news agency Dr Rajah Vijay Kumar, Chairman, Organisation De Scalene said that the device will not kill any bacteria or fungus, however, neutralizes the coronavirus particles.

"The device was tested for its safety and efficacy and is soon going to be manufactured and marketed in the US under the Enforcement Discretion policy of USFDA and in Europe as the device is CE compliant and is CE marked," said Kumar.

He also added the device will cover a volume of 10,000 cubic feet.

The device Scalene Hypercharge Corona Canon (SHYCOCAN) is intended to be used in the residential, industrial and commercial environment and is designed for active containment by attenuation of Corona family of viruses. (Laboratories de Especialidades Immunological S.A. de C.V, Virucidal Activity concludes 99.9 per cent virus elimination), Kumar asserted.

"SHYCOCAN operates on regular 110/240V - 50/60 Hz wall socket and is a plug and play device, that delivers the necessary signals to a photon mediated electrons emitters (PMEE), that produces hypercharge high-velocity electrons by photon mediation that interacts with the negative seeking S-protein of Corona family of viruses thus reducing infectivity and prevent air and surface borne transmission of corona family of viruses," said Kumar.

The device does not use any chemicals, or any other consumables and does not produce harmful ozone gas or any other substances and is completely safe for use in any environment, he added.

"The attack mechanism of the Virus starts with the initial attachment of the virion to the host cell, it is initiated by interactions between the S-protein and its receptor on the "negative" cell membrane. The sites of receptor binding domains (RBD) within the S1 region of a coronavirus S-protein vary depending on the virus. 

The S-protein/receptor interaction is the primary determinant for a coronavirus to infect a host species and governs the tissue tropism of the virus. However, the end result is the fusion and release of the viral genome into the cytoplasm," said Kumar.

He continued saying that the counter mechanism by the device SHYCOCAN is that if negative seeking is the guidance mechanism of the S- Protein, attracted by the transmembrane potential of the host cells, then breaking this mechanism would block the Coronavirus infectivity and spread.

"The device has been in use for more than a year at the S-CARD campus, the headquarters of Scalene," said Kumar.